Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Cloning and Expression
Library Construction
cDNA Synthesis
RNA
RNA
DOCK 180 shRNA Plasmid (h)
Supplier Images
DOCK 180 shRNA Plasmid (h)
DOCK 180 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(10)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
DOCK 180 shRNA Plasmid (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
DOCK 180 shRNA Plasmid (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$592.00
Supplier Page
View Company Product Page
Catalog Number
sc-35207-SH
Quantity
20 µg
Type
shRNA Plasmid
Species
human
NCBI Full Gene Name
dedicator of cytokinesis 1
NCBI Gene Aliases
DOCK180, ced5
RNA Type
shRNA Clones
Vector Type (Standardized)
Lentiviral
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (10)
(1)
EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion
Molecular cancer research : MCR
August 1, 2017
Misek SA, Chen J, Schroeder L, Rattanasinchai C, Sample A, Sarkaria JN, Gallo KA.
(2)
Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31
Neuropathology and applied neurobiology
August 1, 2017
Zhang B, Li H, Yin C, Sun X, Zheng S, Zhang C, Shi L, Liu Y, Lu S.
(3)
Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition
Drug design, development and therapy
January 1, 2016
Chen DJ, Chen W, Jiang H, Yang H, Wang YC, Chen JH.
(4)
Enoxaparin sensitizes human non-small-cell lung carcinomas to gefitinib by inhibiting DOCK1 expression, vimentin phosphorylation, and Akt activation
Molecular pharmacology
January 1, 2015
Pan Y, Li X, Duan J, Yuan L, Fan S, Fan J, Xiaokaiti Y, Yang H, Wang Y, Li X.
(5)
ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models
International journal of cancer
December 1, 2014
Parray A, Siddique HR, Kuriger JK, Mishra SK, Rhim JS, Nelson HH, Aburatani H, Konety BR, Koochekpour S, Saleem M.
(6)
The cooperative action of bacterial fibronectin-binding proteins and secreted proteins promote maximal Campylobacter jejuni invasion of host cells by stimulating membrane ruffling
Cellular microbiology
February 1, 2012
Eucker TP, Konkel ME.
(7)
The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2
Cell communication and signaling : CCS
December 28, 2011
Krause-Gruszczynska M, Boehm M, Rohde M, Tegtmeyer N, Takahashi S, Buday L, Oyarzabal OA, Backert S.
(8)
Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans
The Journal of clinical investigation
December 1, 2011
Feng H, Hu B, Liu KW, Li Y, Lu X, Cheng T, Yiin JJ, Lu S, Keezer S, Fenton T,
et al
.
(9)
Major host factors involved in epithelial cell invasion of Campylobacter jejuni: role of fibronectin, integrin beta1, FAK, Tiam-1, and DOCK180 in activating Rho GTPase Rac1
Frontiers in cellular and infection microbiology
January 1, 2011
Boehm M, Krause-Gruszczynska M, Rohde M, Tegtmeyer N, Takahashi S, Oyarzabal OA, Backert S.
(10)
ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion
Cancer research
August 1, 2007
Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY.
<<
<
>
>>
Reviews
Be the First to Write a Review!
DOCK 180 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$592.00
Product Specs
Company Info
Citations
Reviews
Back To Top